AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
New-onset endometriosis seen in many postmenopausal women. (57% had No History of the Disorder).
SAN DIEGO -- A majority of 50 postmenopausal women diagnosed with endometriosis had no previous history of the disease, a review of cases treated over a 5-year period at one institution found.
Endometriosis is not just a disease of the childbearing years. When pelvic pain, adnexal masses, and other typical signs and symptoms of endometriosis in menopausal or postmenopausal women are present, the disease may indeed be present, Dr. Ash Dabbous said in a poster presentation at the World Congress on Endometriosis.
A total of 42% of these patients were not on hormone replacement therapy (HRT), illustrating that exogenous hormones are not necessary for endometriosis to develop postmenopausally, added Dr. Dabbous, an ob.gyn. at the University of Texas, San Antonio.
In general, endometriotic lesions are believed to depend on estrogen for proliferation and to regress in the absence of ovarian function. There have been previous reports, however, of symptomatic endometriosis recurring in oophorectomized women who were not on HRT.
An estimated 2%-4% of endometriosis cases are ...
- Health issues in postmenopausal women who drink.
- Alcohol Research & Health Register, Thomas C. Cline, J. Mark Shively, Carol A. December 22, 2002 700+ words
...these three diseases in postmenopausal women. The authors stress...potential health effects in postmenopausal women should be interpreted...and well. being of postmenopausal women through the direct...
- FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
- Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS...breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast...
- FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
- Press release article from: PR Newswire July 24, 2007 700+ words
...provide an important option for postmenopausal women at increased risk for breast cancer...cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...
- ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
- News wire article from: AsiaPulse News March 24, 2009 700+ words
...raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23...Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and...and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive...
- Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
- Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer Novartis...associated with cancer treatment in postmenopausal women with early breast cancer. The Novartis...benefit from this information -- postmenopausal women receiving aromatase inhibitor therapy...
- Special Feature: Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs...
- Magazine article from: OB/GYN Clinical Alert January 1, 2004 700+ words
...Feature Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs Expectant Management...and required surgical resection. Postmenopausal women werent supposed to have ovarian...evidence that the vast majority of postmenopausal women with unilocular ovarian cysts up...
- Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of...
- Press release article from: PR Newswire December 7, 2006 700+ words
...risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...and prevention of osteoporosis in postmenopausal women. "If approved, EVISTA would be...
- Lilly's Evista Associated with Significant Reduction of Cardiovascular Events...
- Press release article from: Business Wire February 19, 2002 700+ words
...risk of cardiovascular events in postmenopausal women participating in an osteoporosis...and treatment of osteoporosis in postmenopausal women. Evista is currently being studied...related events and breast cancer in postmenopausal women. The four-year cardiovascular...
